restylane-juvederm.jpg With the introduction of Juvederm dermal filler to eliminate wrinkles, the race between Allergan and Medici’s (maker of Restylane) is supposed to increase. Medici’s Restylane currently dominates the market. Juvederm has been approved by the Food and Drug Administration recently. Meanwhile, Medici’ CEO Shacknai, has said that they are going to bring a product named Reloxin, to compete with Botox directly. In spite of the aggressive marketing strategy by Juvederm overseas, it could not beat Restylane overseas, said Shacknai. Experts feel that despite Allergan and Medici’s claims of difference between the Restylane and Juvederm, there is no significant difference between them.